Literature DB >> 29788770

Synthesis & antitumor activity of epothilones B and D and their analogs.

Hao Cheng1, Gangliang Huang1.   

Abstract

Epothilone is a newly developed antitumor drug; its antitumor principle is to stop the cell cycle by binding to tubulin in tumor cells, promoting tubulin polymerization, inhibiting depolymerization of microtubules, and ultimately inducing apoptosis. There are many analogs of epothilone, such as epothilone B, epothilone D, ixabepilone, sagopilone, 21-amino-epothilone B and KOS-1584. Herein, the synthesis and antitumor activity of epothilones B and D were summed up. The antitumor activity of epothilone analogs was also compared. Synthesis of epothilone and its analogs is more complex, and choosing the proper synthetic method is very important. Moreover, these compounds have obvious antitumor effect. The epothilone and its analogs will continue to play an important role in the future treatment of tumors.

Entities:  

Keywords:  analogs; antitumor activity; epothilones B and D; synthesis

Mesh:

Substances:

Year:  2018        PMID: 29788770     DOI: 10.4155/fmc-2017-0320

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  3 in total

Review 1.  Perspectives and controversies regarding the use of natural products for the treatment of lung cancer.

Authors:  Tingting Wen; Lei Song; Shucheng Hua
Journal:  Cancer Med       Date:  2021-03-02       Impact factor: 4.452

2.  Single-cell transcriptomics reveals the role of Macrophage-Naïve CD4 + T cell interaction in the immunosuppressive microenvironment of primary liver carcinoma.

Authors:  Zhuomao Mo; Daiyuan Liu; Yihan Chen; Jin Luo; Wenjing Li; Jiahui Liu; Ling Yu; Bijun Huang; Shijun Zhang
Journal:  J Transl Med       Date:  2022-10-11       Impact factor: 8.440

Review 3.  A comprehensive review of Rubia cordifolia L.: Traditional uses, phytochemistry, pharmacological activities, and clinical applications.

Authors:  Min Wen; Qi Chen; Wang Chen; Jing Yang; Xiaogang Zhou; Chunxiang Zhang; Anguo Wu; Jia Lai; Jianping Chen; Qibing Mei; Shuo Yang; Cai Lan; Jianming Wu; Feihong Huang; Long Wang
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.